Data Sheet 1_Efficacy and safety of oliceridine in daytime hysteroscopic polypectomy: a ra
by Yuan Wang·Updated 22d ago
1.3 MB1files
Available on 1 platform
Sign in to view source links and access this dataset
Description
A single-center, double-blind, randomized controlled trial enrolled 92 patients aged 18–65 with ASA I–II and BMI 18–30 kg/m² undergoing elective hysteroscopic polypectomy. The study, authored by Yuan Wang and last updated in May 2026, compares the effects of oliceridine, fentanyl, and sufentanil on early recovery and perioperative safety.
Use Cases
Compare Clinical Recovery Scores (CRS) at 5, 10, and 15 minutes post-awakening between different anesthetic regimens.
Analyze time to eye opening and full awakening based on the opioid used during surgery.
Investigate intraoperative vital signs and adverse event rates mentioned in the trial results.
Model the relationship between anesthetic choice and respiratory-related observations like RR and SpO₂.
Strengths
Data originates from a randomized, double-blind, controlled trial design, which suggests a structured experimental setup.
Includes results for 92 patients across three treatment groups (fentanyl n=30, sufentanil n=31, oliceridine n=31).
Primary and secondary outcomes are clearly defined, including Clinical Recovery Score and time-based recovery metrics.
Limitations
Column-level documentation is absent; field semantics must be inferred after download.
Row count is unknown, which may limit suitability assessment.
Data is from a single-center study, which may limit generalizability of findings.